HIGHLIGHTS
- who: Roberta Gualtierotti from the University of Siena, Italy have published the research: Editorial: The molecular mechanisms and therapeutic targets of atherosclerosis, in the Journal: (JOURNAL)
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
SUMMARY
Despite great advancements in tackling ASCVD with the implementation of traditional risk factor-based preventive measures and evidence-based treatment recommendations, risk stratification models still fail to accurately assess cardiovascular (CV) risk. Besides traditional risk factors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.